Cardiff University has an excellent track record of commercially exploiting the outcomes of its research. Forming a company to exploit University know-how or expertise is one of the routes available, and is managed through a close working relationship with Fusion IP. Licensing and royalty agreements, which enable businesses to use Cardiff research commercially, bring enormous benefits to a range of companies. Examples of recent successes are shown below along with current opportunities. If you are interested in obtaining further information please contact us.
Partnership with Tiziana Pharmaceuticals to support work on a novel anti-cancer agent
Share issue conditionally raises £20m for Fusion IP, who have agreed deals to work with Swansea University and the University of Nottingham
MedaPhor group plc, a company spun out of research at Cardiff University, has today floated on the AIM market of the London Stock Exchange
Positive progress for Diurnal's CATCH (Chronocort® As Treatment for Congenital Adrenal Hyperplasia) clinical study
Fault Current Limited (“FCL”), has been awarded a £635,000 grant from the Department of Energy and Climate Change (DECC)
Exclusive distribution agreement with Tellyes Scientific Inc (“Tellyes”) to sell MedaPhor’s range of ultrasound simulators into mainland China
'First-In-Man' Trials Success for Ultravision™ Technology
Cardiff University successfully applied to the Medical Research Council’s Confidence in Concept scheme and was awarded £300,000.